Mucormycosis in patients without cancer: a case series from A tertiary care hospital in South India
- PMID: 24482941
Mucormycosis in patients without cancer: a case series from A tertiary care hospital in South India
Abstract
Background: Mucormycosis (Zygomycosis) is a life-threatening infection. We attempted to analyse clinical features and risk factors of Mucormycosis cases in a tertiary care referral institution in India, in patients without underlying malignancy.
Methods: We retrospectively analyzed data of patients diagnosed as having Mucormycosis over a 10 year period of 2000-2010. Patients with a histopathology report and/or a Microbiology report of Zygomycetes or Mucor from a biopsy specimen were included in the study.
Results: Out of the 27 cases, rhino-orbital/rhino-cerebral involvement occurred in 12 (44.4%) patients, pulmonary involvement in 3 (11.1%) cases, soft tissue involvement in 11 (40.7%) cases and gastrointestinal involvement in one patient (3.7%). Diabetes mellitus is the main risk factor, followed by renal failure and trauma. Mean ESR value of these patients was 118 mm/1 hour. Mean WBC count was 20 x 10(9)/L, and neutrophil count 82%. The mean absolute neutrophil count (ANC) was 16.8 x 10(9)/L.
Conclusion: The interesting finding in our study was the presence of neutrophilic leucocytosis and high ESR in most of the patients. In a predisposed individual, especially in a diabetic, in countries with high environmental fungal burden; presence of high ESR and neutrophilic leucocytosis with a compatible clinical presentation should raise suspicion of Mucormycosis.
Comment in
-
Mucormycosis in patients without cancer: a case series from a tertiary care hospital in South India.J Assoc Physicians India. 2014 Jun;62(6):548. J Assoc Physicians India. 2014. PMID: 25856930 No abstract available.
Similar articles
-
The emergence of mucormycosis as an important opportunistic fungal infection: five cases presenting to a tertiary referral center for mycology.Int J Dermatol. 2007 Apr;46(4):380-4. doi: 10.1111/j.1365-4632.2007.03057.x. Int J Dermatol. 2007. PMID: 17442077
-
Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.Indian J Ophthalmol. 2022 Apr;70(4):1371-1375. doi: 10.4103/ijo.IJO_2943_21. Indian J Ophthalmol. 2022. PMID: 35326057 Free PMC article.
-
Mucormycosis in patients without cancer: a case series from a tertiary care hospital in South India.J Assoc Physicians India. 2014 Jun;62(6):548. J Assoc Physicians India. 2014. PMID: 25856930 No abstract available.
-
Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.J Clin Microbiol. 2006 Mar;44(3):892-8. doi: 10.1128/JCM.44.3.892-898.2006. J Clin Microbiol. 2006. PMID: 16517873 Free PMC article. Review.
-
Diabetes and mucormycosis: a complex interplay.Diabetes Metab. 2012 Jun;38(3):193-204. doi: 10.1016/j.diabet.2012.01.002. Epub 2012 Mar 3. Diabetes Metab. 2012. PMID: 22386924 Review.
Cited by
-
Management of Recurrent Rhinomaxillary Mucormycosis and Nasal Myiasis in an Uncontrolled Diabetic Patient: A Systematic Approach.Int J Appl Basic Med Res. 2018 Apr-Jun;8(2):122-125. doi: 10.4103/ijabmr.IJABMR_22_17. Int J Appl Basic Med Res. 2018. PMID: 29744327 Free PMC article.
-
Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102196. doi: 10.1016/j.dsx.2021.102196. Epub 2021 Jul 3. Diabetes Metab Syndr. 2021. PMID: 34246939 Free PMC article. Clinical Trial.
-
Gastric Mucormycosis Masquerading as Gastric Malignancy.Indian J Surg Oncol. 2017 Sep;8(3):407-410. doi: 10.1007/s13193-016-0554-9. Epub 2016 Sep 8. Indian J Surg Oncol. 2017. PMID: 36118394 Free PMC article.
MeSH terms
LinkOut - more resources
Miscellaneous